Goldman Sachs’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-337,188
| Closed | -$211K | – | 5504 |
|
|
2020
Q4 | $211K | Sell |
337,188
-2,294,397
| -87% | -$1.44M | ﹤0.01% | 4249 |
|
|
2020
Q3 | $1.4M | Sell |
2,631,585
-15,634
| -0.6% | -$8.29K | ﹤0.01% | 3113 |
|
|
2020
Q2 | $1.81M | Buy |
2,647,219
+55,147
| +2% | +$37.8K | ﹤0.01% | 2887 |
|
|
2020
Q1 | $1.94M | Buy |
2,592,072
+32,698
| +1% | +$24.5K | ﹤0.01% | 2780 |
|
|
2019
Q4 | $3.87M | Buy |
2,559,374
+135,859
| +6% | +$205K | ﹤0.01% | 2583 |
|
|
2019
Q3 | $3.59M | Sell |
2,423,515
-17,666
| -0.7% | -$26.1K | ﹤0.01% | 2517 |
|
|
2019
Q2 | $3.15M | Buy |
2,441,181
+1,207,167
| +98% | +$1.56M | ﹤0.01% | 2563 |
|
|
2019
Q1 | $3.22M | Buy |
1,234,014
+883,324
| +252% | +$2.31M | ﹤0.01% | 2686 |
|
|
2018
Q4 | $579K | Buy |
350,690
+319,636
| +1,029% | +$528K | ﹤0.01% | 3358 |
|
|
2018
Q3 | $151K | Sell |
31,054
-32,574
| -51% | -$158K | ﹤0.01% | 3872 |
|
|
2018
Q2 | $398K | Buy |
63,628
+30,493
| +92% | +$191K | ﹤0.01% | 3619 |
|
|
2018
Q1 | $275K | Sell |
33,135
-2,506
| -7% | -$20.8K | ﹤0.01% | 3730 |
|
|
2017
Q4 | $364K | Buy |
+35,641
| New | +$364K | ﹤0.01% | 3580 |
|
|
2016
Q4 | – | Sell |
-15,094
| Closed | -$99K | – | 4615 |
|
|
2016
Q3 | $99K | Buy |
15,094
+3,189
| +27% | +$20.9K | ﹤0.01% | 4183 |
|
|
2016
Q2 | $110K | Buy |
+11,905
| New | +$110K | ﹤0.01% | 4092 |
|
|
2015
Q4 | – | Sell |
-10,820
| Closed | -$227K | – | 4679 |
|
|
2015
Q3 | $227K | Buy |
+10,820
| New | +$227K | ﹤0.01% | 3791 |
|